GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xcorporeal Inc (GREY:XCRP) » Definitions » Cyclically Adjusted Price-to-FCF

Xcorporeal (Xcorporeal) Cyclically Adjusted Price-to-FCF : (As of May. 27, 2024)


View and export this data going back to . Start your Free Trial

What is Xcorporeal Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Xcorporeal Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Xcorporeal's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xcorporeal Cyclically Adjusted Price-to-FCF Chart

Xcorporeal Annual Data
Trend Feb99 Feb00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Xcorporeal Quarterly Data
Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Xcorporeal's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Xcorporeal's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xcorporeal's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xcorporeal's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Xcorporeal's Cyclically Adjusted Price-to-FCF falls into.



Xcorporeal Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Xcorporeal's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2009 is calculated as:

For example, Xcorporeal's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2009 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2009 (Change)*Current CPI (Sep. 2009)
=-0.012/91.1196*91.1196
=-0.012

Current CPI (Sep. 2009) = 91.1196.

Xcorporeal Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
199911 -2.703 71.008 -3.469
200002 -10.222 71.640 -13.001
200005 -6.610 72.358 -8.324
200008 -11.634 72.906 -14.540
200012 -0.012 73.413 -0.015
200103 -0.919 74.341 -1.126
200106 -6.523 75.100 -7.914
200109 6.965 75.227 8.436
200112 -0.081 74.552 -0.099
200203 -4.186 75.438 -5.056
200206 -2.726 75.902 -3.273
200209 2.030 76.366 2.422
200212 -0.194 76.324 -0.232
200303 0.000 77.716 0.000
200306 -0.219 77.505 -0.257
200309 0.000 78.138 0.000
200312 0.000 77.758 0.000
200403 0.000 79.066 0.000
200406 -0.133 80.037 -0.151
200409 -0.038 80.121 -0.043
200412 -0.017 80.290 -0.019
200503 -0.003 81.555 -0.003
200506 -0.009 82.062 -0.010
200509 0.000 83.876 0.000
200512 -0.023 83.032 -0.025
200603 0.000 84.298 0.000
200606 0.000 85.606 0.000
200609 0.000 85.606 0.000
200612 0.000 85.142 0.000
200703 -0.162 86.640 -0.170
200706 -0.143 87.906 -0.148
200709 -0.194 87.964 -0.201
200712 -0.278 88.616 -0.286
200803 -0.246 90.090 -0.249
200806 -0.251 92.320 -0.248
200809 -0.224 92.307 -0.221
200812 -0.164 88.697 -0.168
200903 -0.136 89.744 -0.138
200906 -0.058 91.003 -0.058
200909 -0.012 91.120 -0.012

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Xcorporeal  (GREY:XCRP) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Xcorporeal Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Xcorporeal's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Xcorporeal (Xcorporeal) Business Description

Traded in Other Exchanges
N/A
Address
80 Empire Drive, Lake Forest, CA, USA, 92630
Website
Xcorporeal Inc is a medical device company, developing an innovative extra-corporeal platform technology to be used in devices to replace the function of various human organs.
Executives
Kelly J. Mccrann director, officer: Chairman and CEO 11150 SANTA MONICA BLVD #1500, LOS ANGELES CA 90025
Daniel S Goldberger officer: Chief Executive Officer 24 CARPENTER ROAD, CHESTER NY 10918
Marc G Cummins director C/O PRIME LOGIC CAPITAL, LLC, 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Prime Logic Capital, Llc 10 percent owner 135 EAST 57TH STREET, 11TH FLOOR, NEW YORK NY 10022
Robert Weinstein officer: Chief Financial Officer 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS NV 89169
Terren S Peizer director, 10 percent owner, officer: Executive Chairman 11111 SANTA MONICABLVD STE.500, LOS ANGELES CA 90025
Jay Wolf director 981 LINDA FLORA DRIVE, LOS ANGELES, CA 90049
Herve De Kergrohen director 22 CHEMIN DU NANTET, COLLONGE-BELLERIVE V8 CH1245
Nicholas Sheridan Lewin director 3 WEST 57TH ST., 8TH FLOOR, NEW YORK NY 10019
Lawrence Lacerte 10 percent owner C/O TERAGLOBAL COMMUNICATIONS CORP, 9171 TOWNE CENTRE DRIVE SUITE 600, SAN DIEGO CA 92122

Xcorporeal (Xcorporeal) Headlines